Teresa Cedena
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Selinexor, daratumumab, bortezomib and dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma: results of the phase II, nonrandomized, multicenter GEM-SELIBORDARA study.
Journal: Haematologica
Published: September 20, 2023
Clonal hematopoiesis-defining mutations have no impact on the development of thrombosis in a cohort of patients with myeloid pathology.
Journal: Leukemia research
Published: April 30, 2021
Protein Carbonylation in Patients with Myelodysplastic Syndrome: An Opportunity for Deferasirox Therapy.
Journal: Antioxidants (Basel, Switzerland)
Published: September 11, 2019
Azacitidine improves outcome in higher-risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries.
Journal: British journal of haematology
Published: October 29, 2017
Papain-treated panels are a simple method for the identification of alloantibodies in multiple myeloma patients treated with anti-CD38-based therapies.
Journal: Transfusion medicine (Oxford, England)
Published: June 20, 2017
Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts.
Journal: Annals of hematology
Published: July 27, 2014
Paroxysmal nocturnal hemoglobinuria: a single Spanish center's experience over the last 40 yr.
Journal: European journal of haematology
Published: April 10, 2014
Transfusion dependence development and disease evolution in patients with MDS and del(5q) and without transfusion needs at diagnosis.
Journal: Leukemia research
Published: September 08, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026